GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eurofins Scientific SE (OTCPK:ERFSF) » Definitions » Total Assets

Eurofins Scientific SE (Eurofins Scientific SE) Total Assets : $11,874 Mil (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Eurofins Scientific SE Total Assets?

Eurofins Scientific SE's Total Assets for the quarter that ended in Dec. 2023 was $11,874 Mil.

During the past 12 months, Eurofins Scientific SE's average Total Assets Growth Rate was 0.70% per year. During the past 3 years, the average Total Assets Growth Rate was 8.10% per year. During the past 5 years, the average Total Assets Growth Rate was 8.00% per year. During the past 10 years, the average Total Assets Growth Rate was 23.10% per year.

During the past 13 years, Eurofins Scientific SE's highest 3-Year average Total Assets Growth Rate was 52.60%. The lowest was 4.70%. And the median was 22.80%.

Total Assets is connected with ROA %. Eurofins Scientific SE's annualized ROA % for the quarter that ended in Dec. 2023 was 3.00%. Total Assets is also linked to Revenue through Asset Turnover. Eurofins Scientific SE's Asset Turnover for the quarter that ended in Dec. 2023 was 0.31.


Eurofins Scientific SE Total Assets Historical Data

The historical data trend for Eurofins Scientific SE's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurofins Scientific SE Total Assets Chart

Eurofins Scientific SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,692.33 10,432.48 10,544.97 10,681.67 11,874.16

Eurofins Scientific SE Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,544.97 10,846.51 10,681.67 11,178.66 11,874.16

Eurofins Scientific SE Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Eurofins Scientific SE's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=5602.399+6271.756
=11,874

Eurofins Scientific SE's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (Q: Dec. 2023 )+Total Liabilities (Q: Dec. 2023 )
=5602.399+6271.756
=11,874

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eurofins Scientific SE  (OTCPK:ERFSF) Total Assets Explanation

Total Assets is connected with ROA %.

Eurofins Scientific SE's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=346.128/( (11178.657+11874.155)/ 2 )
=346.128/11526.406
=3.00 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Eurofins Scientific SE's Asset Turnover for the quarter that ended in Dec. 2023 is

Asset Turnover
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=3604.253/( (11178.657+11874.155)/ 2 )
=3604.253/11526.406
=0.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Eurofins Scientific SE Total Assets Related Terms

Thank you for viewing the detailed overview of Eurofins Scientific SE's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Eurofins Scientific SE (Eurofins Scientific SE) Business Description

Traded in Other Exchanges
Address
23 Val Fleuri, Luxembourg, LUX, L-1526
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 900 laboratories in 61 countries. Its revenue from Europe, North America, and the Rest of the World contribute approximately 50%, 40%, and 10% of total revenue respectively. Its main business activities are food and environmental testing, biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.